SHM Converge Meeting News Central
  • hospitalmedicine.org
  • Daily Coverage
  • Program
  • Engagement Arena
  • Awards and Events
  • Previews
Topics
  • Daily Coverage
  • Program
  • Engagement Arena
  • Awards and Events
  • Previews
Resources
  • Special events
  • Conference FAQs
  • Claiming CME and Other Credits
  • SHM Converge 2024
Twitter X icon Facebook iconInstagram iconLinkedIn icon
Mar 7th, 2022

So you think you know pneumonia?

Pneumonia may be considered a common illness, but there are developments in diagnosis and treatment happening every day.


Josue Zapata, MD
Josue Zapata, MD

With the focus on COVID-19 over the past two years, other extremely common respiratory illnesses like community-acquired pneumonia could get overlooked. But plenty has been  happening in that field, including debates over the use of novel markers and therapeutics.

Josue Zapata, MD, associate professor of clinical medicine and associate chief of the Medical Service at the San Francisco VA Medical Center, said there has been a lot of debate in the last few years about the role of procalcitonin—a blood marker that correlates with bacterial infection—in the diagnosis and treatment of pneumonia.

“Hospitalists know about the harms of overtreatment and the need for judicious antibiotic use. The use of procalcitonin to curb excess antibiotic use seemed like a great step forward in balancing benefits and risks for one of the most common reasons for hospitalization and for antibiotic use in the U.S.,” Dr. Zapata said. “Just a few years ago, I had never heard of procalcitonin, then it seemed like suddenly it was all the rage. I was rapidly trying to figure out how to use it and adapt it into my practice to better care for patients.”

Dr. Zapata said his initial enthusiasm for procalcitonin was replaced by confusion and that complexity is something he plans to address in the session “Blue Jeans and Blue Lips: Updates in Pneumonia.”

“As more and more studies came out showing the benefits, challenges, and pitfalls of using procalcitonin, I found myself more and more puzzled about what I should be doing,” he said. “Through case examples, we hope to shed some light on why there has been so much debate and how hospitalists should view the use of procalcitonin in 2022.”

Dr. Zapata said another change in the treatment of pneumonia has been a gradual move to shorter and shorter antibiotic courses as the field of medicine has developed more appreciation for the harms associated with antibiotic overuse. Plus, more studies have emerged suggesting shorter courses are just as good as longer courses.

“We know from the data that many patients are being prescribed unnecessarily long antibiotic courses even by current standards. In addition to moving clinical practice closer to the guidelines, there is also a question about how short we can go,” he said. “Infectious Disease Society of America guidelines suggest at least five days, but some new evidence in the last year or so has really pushed the envelope beyond that. We’ll review why the current guidelines are the way that they are and how we are integrating this new data into our practice.”

Although pneumonia may be considered a common illness, Dr. Zapata said there is still a lot that even the most seasoned hospitalist may not know about the latest in its treatment.

“Our hope is that clinicians will get some new information that likely confirms what they are already doing in practice, but perhaps they never understood the exact evidence behind it,” he said. “There is a tremendous amount of nuance and art in using the evidence to provide optimal treatment for patients. I suspect that many hospitalists who thought that they knew a great deal about pneumonia will be surprised by some of the insights and discourse.”

Visit SHM Meeting News Central for more coverage.

 

Interesting Stories
Excellence in Teamwork
Sponsored by SHM
Excellence in Teamwork
The Hospitalist Editorial Board Members’ Top SHM Converge 2023 Sessions
Sponsored by SHM
The Hospitalist Editorial Board Members’ Top SHM Converge 2023 Sessions
More Content
Head shot of Christopher Whinney
Previews
Reconnect at SHM Converge 2023
Feb 22nd, 2023
Head shot of Nirmish Shah, MD
Previews
Managing the most common issue in sickle cell patients
Feb 21st, 2023
Comedian Thom Tran
Previews
Laughing in the face of adversity
Feb 22nd, 2023
Overhead view of people mingling
Previews
Take advantage of networking and learning opportunities at Converge
Feb 21st, 2023
Head shot of Jocelyn Zee, DO, FAAFP, SFHM, and Alice Gallo De Moraes, MD
Previews
Knowing when to call for help — and how to manage when you can’t
Feb 20th, 2023
Head shots of Gopi Astik and Joanna Bonsall
Previews
Charting a path forward
Feb 20th, 2023
Meeting hall table set for breakfast
Previews
Start the day—and the conference—off on the right foot
Mar 7th, 2022
Jocelyn Zee, DO, FAAFP, SFHM
Previews
Critical knowledge for critical care
Mar 7th, 2022
Rachel Cyrus, MD
Previews
Facing the next phase
Mar 7th, 2022
Nashville street
Previews
Welcome back, Nashville awaits
Mar 7th, 2022
Elham Yousef, MD, MBA, MSC, FACP, SFHM
Previews
Barriers, pitfalls, and myths: a framework for advancement for women in medicine
Mar 7th, 2022
Overhead view of Music City Center in Nashville
Daily Coverage
Save the date for SHM Converge 2022
Feb 18th, 2022
SHM Converge Meeting News Central
Twitter X icon Facebook iconInstagram iconLinkedIn icon

Society of Hospital Medicine
1500 Spring Garden, Suite 501
Philadelphia, PA 19130

Phone: 800-843-3360
Fax: 267-702-2690
[email protected]